Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

University of Southern California

Status

Enrolling

Conditions

Prostate Carcinoma

Treatments

Other: Non-Interventional Study

Study type

Observational

Funder types

Other

NIH

Identifiers

NCT06067295

NCI-2023-01434 (Registry Identifier)

P30CA014089 (U.S. NIH Grant/Contract)

4P-22-2 (Other Identifier)

Details and patient eligibility

About

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

Full description

PRIMARY OBJECTIVE:

I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer.

OUTLINE: This is an observational study.

Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

Enrollment

300 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Men of all racial and ethnic groups 18 years of age or older
Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
Prior participation on clinical trials is allowed

Exclusion criteria

Inability to give informed consent
Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer